Dominik Bettenworth
Overview
Explore the profile of Dominik Bettenworth including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
3807
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sturm A, Atreya R, Bettenworth D, Bokemeyer B, Dignass A, Ehehalt R, et al.
Z Gastroenterol
. 2024 Aug;
62(8):1229-1318.
PMID: 39111333
No abstract available.
2.
Fererberger T, Buechler C, Kandulski A, Elger T, Loibl J, Schmid S, et al.
Front Med (Lausanne)
. 2024 Jun;
11:1334865.
PMID: 38895187
Intoduction: Identification of specific metabolome and lipidome profile of patients with primary sclerosing cholangitis (PSC) is crucial for diagnosis, targeted personalized therapy, and more accurate risk stratification. Methods: Nuclear magnetic...
3.
Adamina M, Minozzi S, Warusavitarne J, Buskens C, Chaparro M, Verstockt B, et al.
J Crohns Colitis
. 2024 Jun;
18(10):1556-1582.
PMID: 38878002
This article is the second in a series of two publications on the European Crohn's and Colitis Organisation [ECCO] evidence-based consensus on the management of Crohn's disease. The first article...
4.
Gordon H, Minozzi S, Kopylov U, Verstockt B, Chaparro M, Buskens C, et al.
J Crohns Colitis
. 2024 Jun;
18(10):1531-1555.
PMID: 38877997
No abstract available.
5.
Bettenworth D, Baker M, Fletcher J, Jairath V, Lu C, Bemelman W, et al.
Nat Rev Gastroenterol Hepatol
. 2024 Jun;
21(8):572-584.
PMID: 38831007
Fibrostenosis of the small bowel is common in patients with Crohn's disease. No consensus recommendations on definition, diagnosis and management in clinical practice are currently available. In this Consensus Statement,...
6.
Poulsen A, Ovesen P, Lu C, Bettenworth D, Jairath V, Feagan B, et al.
J Crohns Colitis
. 2024 May;
18(11):1894-1934.
PMID: 38758527
Background And Aim: Contemporary techniques to assess disease activity or bowel damage in patients with inflammatory bowel disease [IBD], such as endoscopy and imaging, are either invasive or lack accuracy....
7.
Tews H, Schmelter F, Kandulski A, Buchler C, Schmid S, Schlosser S, et al.
Inflamm Bowel Dis
. 2023 Dec;
30(12):2405-2417.
PMID: 38156773
Background: Accurate biomarkers for disease activity and progression in patients with inflammatory bowel disease (IBD) are a prerequisite for individual disease characterization and personalized therapy. We show that metabolic profiling...
8.
Kumar A, Yassin N, Marley A, Bellato V, Foppa C, Pellino G, et al.
Therap Adv Gastroenterol
. 2023 Dec;
16:17562848231218615.
PMID: 38144422
An estimated 2.5-3 million individuals (0.4%) in Europe are affected by inflammatory bowel disease (IBD). Whilst incidence rates for IBD are stabilising across Europe, the prevalence is rising and subsequently...
9.
Bokemeyer A, Buskermolen J, Ketelhut S, Tepasse P, Vollenberg R, Trebicka J, et al.
J Clin Med
. 2023 Jun;
12(12).
PMID: 37373760
Ulcerative colitis (UC) is characterized by chronic inflammation of the colorectum. Histological remission has emerged as a potential future treatment goal; however, the histopathological assessment of intestinal inflammation in UC...
10.
Wessling J, Kucharzik T, Bettenworth D, Luegering A, Maaser C, Grenacher L, et al.
Rofo
. 2023 May;
195(8):675-690.
PMID: 37137321
Background: MR-enterography/enteroclysis (MRE) is increasingly used for primary diagnosis, detection of complications, and monitoring of patients with inflammatory bowel disease (IBD). Standardization of reporting is relevant to ensure quality of...